<b><a href="myelostat.htm" class="texte">Myelostat Regulatory status.</a></b> <br> <br> Hemi-synthetic homoharringtonine is still not marketed. It is commonly prescribed for compassionate use in France, to named patients.<br> Based on the product extensive bibliography, an <a href="myelostat_status.htm">orphan drug status</a> was<br> obtained for Europe in 2004 in CML and in AML indications, and submissions<br> are in preparation for the USA.
About Stragen
|
Contact
|
Sitemap
|
Legal Notices
© 2005
Stragen
Pharma SA - All rights reserved
